~~<i id='09175FF003'><strike id='09175FF003'><tt id='09175FF003'><pre id='09175FF003'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：comprehensive 2025-09-28 06:43:32 Page View：84

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The Bio Revolution is changing business and society
Next article： Alkermes shareholders re

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Asahi Kasei to buy Calliditas, picking up kidney disease drug

AdobeLONDON—Seekingtobuildupitspharmabusiness,theJapaneseconglomerateAsahiKaseiismovingtobuySwedishb

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

Should insurance cover cosmetic surgery?

ATTAKENARE/AFP/GettyImagesShouldinsurancecoverbreastaugmentation,theprocedurecommonlyknownasaboobjob